Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 489.39M | 650.25M | 681.74M | 666.99M | 668.18M |
| Total Depreciation and Amortization | 231.01M | 224.67M | 222.02M | 211.62M | 201.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.49M | 60.44M | 10.53M | 32.17M | 33.70M |
| Change in Net Operating Assets | -139.69M | -209.47M | -232.47M | -296.12M | -357.93M |
| Cash from Operations | 637.20M | 725.90M | 681.82M | 614.66M | 545.56M |
| Capital Expenditure | -263.24M | -303.78M | -313.71M | -343.85M | -324.94M |
| Sale of Property, Plant, and Equipment | 3.41M | 1.63M | 2.83M | 4.09M | 6.12M |
| Cash Acquisitions | -33.33M | -19.12M | -19.12M | -633.24M | -633.24M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -436.00M | -281.50M | -221.85M | 302.79M | 263.39M |
| Cash from Investing | -729.16M | -602.77M | -551.85M | -670.22M | -688.68M |
| Total Debt Issued | 20.26B | 6.75B | -391.00M | 13.99B | 24.49B |
| Total Debt Repaid | -1.26B | -1.11B | -1.12B | -1.32B | -1.29B |
| Issuance of Common Stock | 397.00M | 329.00M | 324.00M | 370.00M | 193.00M |
| Repurchase of Common Stock | -- | -1.39B | -1.39B | -1.39B | -1.39B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -76.27M | -76.27M | -76.27M | -79.53M | -79.53M |
| Other Financing Activities | -4.44B | -4.05B | -4.07B | 3.17B | 3.57B |
| Cash from Financing | 86.70M | -72.87M | -153.19M | 100.59M | 229.02M |
| Foreign Exchange rate Adjustments | 13.75M | 11.04M | 6.96M | 4.45M | 2.59M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.48M | 61.29M | -16.26M | 49.48M | 88.49M |